Literature DB >> 30354014

Cell-Selective Delivery of MicroRNA with a MicroRNA-Peptide Conjugate Nanocomplex.

Xiao Xiao1, Xingxing Wang1, Haidong Gao2, Xi Chen2, Jinbo Li1,2, Yan Zhang1,2.   

Abstract

Targeted delivery of microRNA (miRNA) into specific cells has been regarded as an efficient strategy to enhance miRNA-targeted therapeutics. However, concurrent delivery of therapeutic miRNAs into different target cells that is conducive to multi-target therapy is still underdeveloped. Here, we report a novel strategy for cell-selective delivery of miRNA into different target cells by using miRNA nanocomplexes (MINRCs) formed by miRNA with peptide conjugates. The peptide conjugates comprised a cationic cell-penetrating peptide nona-arginine and a targeting ligand that is cyclic RGD or folic acid. Upon mixing in buffer, the peptide conjugates and miR-34a readily formed two MINRCs, respectively. These two MINRCs facilitated the targeted delivery of miR-34a into RGD receptor-positive U87MG cells or folate receptor-positive HeLa cells via ligand-receptor interaction. We also demonstrated that co-incubation of these two MINRCs with U87MG and HeLa cells led to cell-selective delivery of miR-34a.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cell-selective delivery; microRNA; microRNA nanocomplex; peptide conjugate; targeted delivery

Mesh:

Substances:

Year:  2018        PMID: 30354014     DOI: 10.1002/asia.201801396

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  4 in total

Review 1.  Supramolecular Assemblies of Peptides or Nucleopeptides for Gene Delivery.

Authors:  Huaimin Wang; Zhaoqianqi Feng; Bing Xu
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 2.  Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation.

Authors:  Jin Wang; Tian Tian; Xin Li; Yan Zhang
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

3.  Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway.

Authors:  Xin Liu; Chao Dong; Siping Ma; Yongpeng Wang; Tao Lin; Yanxi Li; Shihua Yang; Wanchuan Zhang; Rui Zhang; Guohua Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances.

Authors:  Hua Jin; Xiao Lin; Mengyue Gao; Liao Cui; Yun Liu
Journal:  Front Chem       Date:  2020-10-28       Impact factor: 5.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.